Mattia Rosso, MD
Clinical FellowAbout
Titles
Clinical Fellow
Appointments
Education & Training
- MHS-Med Ed
- Yale School of Medicine (2027)
- Clinical Fellow in Movement Disorders
- Yale New Haven Hospital (2026)
- Neurology Resident
- Medical University of South Carolina (2024)
- Chief Resident
- Medical University of South Carolina (2024)
- Postdoctoral Research Fellow
- Brigham and Women’s Hospital (2020)
- MD
- Università Vita-Salute San Raffaele (2017)
- Medical Student
- Università Vita-Salute San Raffaele (2017)
Board Certifications
Neurology
- Certification Organization
- ABPN
- Original Certification Date
- 2024
Research
Publications
2026
Dancing in Chaos: The Need for a Classification System for Chorea
Patino J, Mahajan A, Mendizabal A, Moore K, Zuchowski K, Rosso M, Espay A, Bang J, Testa C, Duker A, Walker R, Stimming E, Santini V. Dancing in Chaos: The Need for a Classification System for Chorea. Movement Disorders Clinical Practice 2026, 13: 1187-1191. PMID: 41527249, PMCID: PMC13172764, DOI: 10.1002/mdc3.70505.Peer-Reviewed Original Research
2025
The Influence of Videography in the Foundation and Future of Movement Disorders
Rosso M, Chu D, Barton B. The Influence of Videography in the Foundation and Future of Movement Disorders. Movement Disorders Clinical Practice 2025, 13: 359-368. PMID: 40857050, PMCID: PMC12911520, DOI: 10.1002/mdc3.70299.Peer-Reviewed Original ResearchConceptsMovement disordersAmerican AcademyIn-person examinationEducation of neurologistsAmerican Academy of NeurologyDiagnosis of movement disordersIn-personPatient recordsNeurology educationClinical disciplinesRating ScaleVideo recordingsTelemedicineClinical researchParoxysmal movement disordersClinical examinationNeurologyEducationDevelopment of video technologyHistorical developmentDisordersRecordsSubspecialtyThe Influence of Videography in the Foundation and Future of Movement Disorders
Rosso M, Chu D, Barton B. The Influence of Videography in the Foundation and Future of Movement Disorders. Mov Disord Clin Pract. 2025 Aug 26. doi: 10.1002/mdc3.70299. Epub ahead of print. PMID: 40857050.Peer-Reviewed Original ResearchA20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGAD
Lechner C, Saxena S, Lokhande H, Breu M, Eisenkölbl A, Karenfort M, Klein A, Leiz S, Preisel M, Rooney T, Rosso M, Schimmel M, Wendel E, Reindl M, Baumann M, Rostasy K, Chitnis T. A20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGAD. Neurology Neuroimmunology & Neuroinflammation 2025, 12: e200452. PMID: 40825157, PMCID: PMC12363411, DOI: 10.1212/nxi.0000000000200452.Peer-Reviewed Original ResearchConceptsMOG-IgG-associated disorderNeuromyelitis optica spectrum disorderPediatric patientsAnti-inflammatory roleA20 levelsDisease courseMultiple sclerosisSmall group of pediatric patientsCohort of pediatric patientsGroup of pediatric patientsMonophasic disease courseClinically isolated syndromeMOG-IgG titersMyelin oligodendrocyte glycoproteinAnalysis of patientsPatient's first symptomsSerum samplesTime pointsStandardized time pointsLongitudinal evaluationAQP4-IgGUntreated patientsOligodendrocyte glycoproteinImmunomodulatory treatmentPrognostic implicationsLaunching the Neurohumanities Network: An Online, Trainee-Led, Transdisciplinary Collaborative Effort to Foster Understanding of the Arts, Humanities, and Neurosciences (P5-5.004)
Doolittle J, Lewis C, Gheihman G, Rosso M, Palmer C, Stanley M. Launching the Neurohumanities Network: An Online, Trainee-Led, Transdisciplinary Collaborative Effort to Foster Understanding of the Arts, Humanities, and Neurosciences (P5-5.004). Neurology 2025, 104 DOI: 10.1212/wnl.0000000000211302.Peer-Reviewed Original Research
2024
Education Research: The Neurohumanities in Training
Rosso M, Greige T, Palmer C, Peng G, Ardakani R, Frolov A, George M, Carandang R, Gheihman G, Stanley M. Education Research: The Neurohumanities in Training. Neurology Education 2024, 3: e200178. PMID: 39748894, PMCID: PMC11694799, DOI: 10.1212/ne9.0000000000200178.Peer-Reviewed Original ResearchResidency trainingNeurology residency trainingClinical practiceNeurology residency programsAspects of medicineConvenience sampleMedical educationMedical studentsResidency programsNeurology trainingNeurologySubjective aspectsStressful eventsPrimary audienceScholarly explorationSkill enhancementSubjective sphereTrainingTarget audienceResidentsProgramUnited StatesAudienceCurriculaDebriefing
2023
A20 (TNFAIP3) Distinguishes Relapse from Remission in Pediatric Patients with Monophasic MOGAD: Preliminary Results
Lechner C, Saxena S, Lokhande H, Breu M, Eisenkölbl A, Karenfort M, Klein A, Leiz S, Preisel M, Rooney T, Rosso M, Schimmel M, Wendel E, Reindl M, Baumann M, Rostasy K, Chitnis T. A20 (TNFAIP3) Distinguishes Relapse from Remission in Pediatric Patients with Monophasic MOGAD: Preliminary Results. Neuropediatrics 2023, 54: s1-s32. DOI: 10.1055/s-0043-1777141.Peer-Reviewed Original Research
2022
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS
Lokhande H, Rosso M, Tauhid S, Chu R, Healy B, Saxena S, Barro C, Paul A, Polgar-Turcsanyi M, Anderson M, Glanz B, Kropshofer H, Granziera C, Leppert D, Kappos L, Kuhle J, Weiner H, Bakshi R, Chitnis T. Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS. Multiple Sclerosis Journal - Experimental Translational And Clinical 2022, 8: 20552173211069348. PMID: 35035990, PMCID: PMC8753083, DOI: 10.1177/20552173211069348.Peer-Reviewed Original ResearchDeep gray matterSNfL levelsMultiple sclerosisSingle molecule arraySerum neurofilament light chainAssociated with relapseYears of disease onsetSerum NfL levelsSerum neurofilament lightBrain volumeAnnual blood samplesHigh-resolution 3-T MRICortical thicknessNeurofilament light chainYear 1Thalamic fractionComprehensive Longitudinal InvestigationMRI lesionsMRI outcomesGlobal cortical thicknessRegional brain volumesWomen's HospitalThalamic volumeSNfLPrognostic biomarker
2021
Gaetano Perusini: The Forgotten Neuroscientist Behind “Alzheimer’s” Disease
Pellegrini F, Rosso M, Chu D. Gaetano Perusini: The Forgotten Neuroscientist Behind “Alzheimer’s” Disease. The Neuroscientist 2021, 29: 273-276. PMID: 34836480, DOI: 10.1177/10738584211059466.Peer-Reviewed Original ResearchTemporal trends of multiple sclerosis disease activity: Electronic health records indicators
Liang L, Kim N, Hou J, Cai T, Dahal K, Lin C, Finan S, Savovoa G, Rosso M, Polgar-Tucsanyi M, Weiner H, Chitnis T, Cai T, Xia Z. Temporal trends of multiple sclerosis disease activity: Electronic health records indicators. Multiple Sclerosis And Related Disorders 2021, 57: 103333. PMID: 35158446, PMCID: PMC8849591, DOI: 10.1016/j.msard.2021.103333.Peer-Reviewed Original ResearchConceptsElectronic health record dataElectronic health recordsElectronic health record measureRegistry dataClinic-based cohortEmergency room visitsTemporal trendsProcedure codesHealth recordsElectronic prescriptionsHealth utilityMultiple sclerosisDiagnostic codesRoom visitsLong-term disease activityDisease activityRegistryClinical settingLarge-scale examinationRelapse ratePatient monitoringPrescriptionRecord indicatorsInflammatory disease activityMS patients
Academic Achievements & Community Involvement
Get In Touch
Contacts
Mailing Address
Yale School of Medicine
20 York Street
New Haven, Connecticut 06510
United States